Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 24.92B | 23.77B | 23.06B | 21.93B | 19.41B |
Gross Profit | 6.98B | 6.68B | 6.52B | 7.62B | 6.71B |
EBITDA | 1.89B | 2.66B | 1.69B | 3.10B | 1.85B |
Net Income | 101.13M | 948.71M | 1.59B | 1.41B | 501.57M |
Balance Sheet | |||||
Total Assets | 32.49B | 32.25B | 31.35B | 27.66B | 24.03B |
Cash, Cash Equivalents and Short-Term Investments | 3.31B | 3.51B | 2.99B | 3.33B | 2.56B |
Total Debt | 4.21B | 4.66B | 5.67B | 2.39B | 1.33B |
Total Liabilities | 8.02B | 8.23B | 8.86B | 6.81B | 4.53B |
Stockholders Equity | 24.41B | 23.99B | 22.46B | 20.85B | 19.50B |
Cash Flow | |||||
Free Cash Flow | 564.48M | 1.76B | -3.12B | -250.08M | 79.72M |
Operating Cash Flow | 2.46B | 3.41B | -1.59B | 1.89B | 1.33B |
Investing Cash Flow | -1.98B | -1.63B | -1.93B | -1.86B | -1.05B |
Financing Cash Flow | -672.18M | -1.30B | 2.99B | 867.56M | 473.86M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥3.96B | 6.56 | 1.52% | 0.28% | -27.08% | ||
75 Outperform | ¥3.70B | 8.11 | 4.00% | 15.75% | 44.95% | ||
74 Outperform | ¥8.14B | 3.97 | 2.75% | 0.90% | ― | ||
72 Outperform | ¥6.36B | 11.88 | 2.28% | 7.48% | 10.02% | ||
67 Neutral | ¥271.27B | 14.33 | 6.84% | 2.52% | 5.08% | -22.38% | |
55 Neutral | ¥7.83B | 65,670.10 | 5.65% | -1.39% | -99.93% | ||
52 Neutral | ¥10.65B | 380.37 | 4.15% | 0.89% | -99.30% |